Clinical Trials on HIV Disease

Total 383326 results

University of British Columbia
National Institute of Mental Health (NIMH)

Unknown

WelTel Retain: Promoting Engagement in Pre-ART HIV Care Through SMS

HIV

Kenya
Oswaldo Cruz Foundation
University of Sao Paulo; Centro de Referência e Treinamento DST AIDS

Unknown

Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project. (PrEPBrasil)

HIV

Brazil
Holdsworth House Medical Practice
Gilead Sciences

Completed

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia (RiC)

HIV

Australia
Anna Cruceta

Completed

Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine (A-TRI-WEEK)

HIV

Spain
University of California, San Francisco
San Francisco Jail Health Services - HIV and Integrated Services; San Francisco...

Completed

The Navigator Project (NAV)

HIV

United States
University of Washington

Completed

Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa

HIV

South Africa, Uganda
Emory University
National Institute of Mental Health (NIMH)

Completed

Couples HIV Counseling and Testing for Male Couples in the United States (CVCT)

HIV

United States
North Bronx Healthcare Network

Withdrawn

Project TEACH-Kenya (TEACH)

HIV

United States, Kenya
Universiti Putra Malaysia

Completed

Effectiveness of Clinician Client Centered Counseling on Sexual Behaviors of Antiretroviral Therapy Patients in Nigeria

HIV
Public Health Foundation Enterprises, Inc.
National Institute of Mental Health (NIMH)

Completed

Examining Hair to Determine Tenofovir Exposure

HIV

United States
CONRAD

Completed

Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine

HIV

United States
The HIV Netherlands Australia Thailand Research...
Chulalongkorn University; Khon Kaen University

Completed

PK TDF in Thai HIV-infected Children

HIV

Thailand
Hopital Foch
Saint-Louis Hospital, Paris, France; INSERM UMR912-SE4S, Marseille, France

Completed

Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital (RAVVIH)

HIV

France
Indiana University

Completed

Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics

HIV

United States
University of Southern California
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

HIV

United States
Charles Drew University of Medicine and Science
University of California, Los Angeles; National Institute on Minority Health... and other collaborators

Completed

Men of African American Legacy Empowering Self (MAALES)

HIV

United States
Imperial College London
CUT'HIVAC Cutaneous HIV Vaccination

Unknown

Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes (CUT*HIVAC001)

HIV

United Kingdom
University of California, San Francisco

Terminated

A Case Management Intervention to Prevent ER Visits in HIV-infected Persons

HIV

United States
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Shaping the Health of Adolescents in Zimbabwe (SHAZ!)

HIV

Zimbabwe
Lighthouse Trust
University of North Carolina, Chapel Hill; World Health Organization; Kamuzu... and other collaborators

Unknown

Promoting Uptake and Retention of Option B+ in Malawi (PURE)

HIV

Malawi
Moi University
United States Agency for International Development (USAID)

Unknown

Modified Directly Observed Antiretroviral Therapy (M-DART)

HIV

Kenya
Kirby Institute
The HIV Netherlands Australia Thailand Research Collaboration

Completed

The Neurocognitive Sub-study of Encore1

HIV

Thailand
Holdsworth House Medical Practice
Bristol-Myers Squibb

Completed

Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia (REfLecT)

HIV

Australia
Bristol-Myers Squibb
PharmaNet

Completed

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting (REMAIN)

HIV

Germany, Spain, Portugal
Tibotec, Inc
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers

HIV
Cytheris SA

Terminated

Study on Interleukin-7 (CYT107) in HIV Patients (Inspire 2)

HIV

United States, Canada
St Stephens Aids Trust

Completed

Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers

HIV

United Kingdom
Bristol-Myers Squibb

Completed

Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects

HIV

United States
Kenneth H. Mayer, MD
Bristol-Myers Squibb; Gilead Sciences; Abbott

Terminated

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV (BMS PEP)

HIV

United States
Bristol-Myers Squibb

Completed

Comparative Tolerability of Protease Inhibitors

HIV
Fundación FLS de Lucha Contra el Sida, las Enfermedades...

Completed

Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment

HIV

Spain
Oklahoma State University Center for Health Sciences

Completed

Electronic Intervention for HIV Medication Adherence

HIV

United States
Centers for Disease Control and Prevention

Completed

The Treatment Advocacy Program

HIV

United States
University of California, San Francisco
National Center for Complementary and Integrative Health (NCCIH)

Completed

Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV

HIV

United States
Chelsea and Westminster NHS Foundation Trust
King's College Hospital NHS Trust; Public Health England; Department of Health... and other collaborators

Completed

HIV Testing in Non-traditional Settings Study (HINTS)

HIV

United Kingdom
Case Western Reserve University
Association of Nurses in AIDS Care

Completed

Study of SystemCHANGE-HIV

HIV

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

HIV
St Stephens Aids Trust

Completed

Raltegravir and Ezetimibe PK Study

HIV

United Kingdom
St Stephens Aids Trust

Completed

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

HIV

United Kingdom
Gilead Sciences

Completed

Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.

HIV
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
Johann Wolfgang Goethe University Hospital
Gilead Sciences

Unknown

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

HIV

Germany
Biosyn
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

HIV

United States
Florida International University
University of Southern California; Universidad Peruana Cayetano Heredia

Recruiting

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

HIV Infections | Sexually Transmitted Diseases | Hiv | Sexual Behavior | Risk Reduction | Sexually Transmitted Infections (Not HIV or Hepatitis)

United States
Indiana University

Recruiting

Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women

HIV Infections | HIV/AIDS | Cervical Dysplasia

Kenya, United States, Uganda
Case Western Reserve University
American Heart Association

Completed

A Clinical Trial of SystemCHANGE to Improve Exercise, Diet and Health in HIV-Infected Adults

Cardiovascular Disease | HIV

United States
St Vincent's Hospital, Sydney
Merck Sharp & Dohme LLC

Completed

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. (ROaR+)

Cardiovascular Disease | HIV

Australia
Duke University
National Cancer Institute (NCI)

Terminated

Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions

Newly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating Oncologist

United States
GlaxoSmithKline

Terminated

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (ELEVATE)

Liver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B Virus

United States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina
RTI International
Centers for Disease Control and Prevention

Completed

Positive Health Check Evaluation Trial ((PHC))

Human Immunodeficiency Virus (HIV) Positive

United States

Clinical Trials on HIV Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations